Government Affairs
Refine Search
Pharmaceutical
The Dutch Presidency of the European Union Council appears to be keeping its cards close to its chest as far as pharmaceuticals and public health is concerned. 5 February 2016
Generics
Chip Davis, president and chief executive of the US Generic Pharmaceutical Association (GPhA), on Monday briefed Congress about the ways generic drugs and biosimilars can drive savings in terms of healthcare cost, at a hearing of the Senate Committee on Health, Education, Labor and Pensions (HELP). 3 February 2016
Pharmaceutical
Capitalizing on export opportunities in regulated and semi-regulated markets has been the way forward for the Indian pharmaceutical sector, with exports set to cross $55 billion by 2020 versus current exports of $18 billion. 1 February 2016
Pharmaceutical
The pharmaceutical industry has come under the spotlight over the Zika crisis after US President Barack Obama urged a rapid response to the outbreak. 28 January 2016
Biotechnology
The association which represents the life sciences industry in France has called on the country’s government to inject more funds into innovation. 27 January 2016
Generics
As reported in Indian media, senior officials from the European Commission and India are expected to meet today in Brussels to hold talks on resuming negotiations on the proposed European Union-India free trade agreement. 18 January 2016
Biosimilars
Generic and biosimilar medicines represent an essential opportunity to optimize the efficiency of healthcare systems in Italy, according to an article published this week in the Journal of Generic Medicines, Generic and Biosimilar Medicines Use and Expenditure: A Report from the National Observatory on the Use of Medicines (OsMed) of the Italian Medicines Agency (AIFA). 12 January 2016
Generics
In response to a recent hearing of the US Senate Special Committee on Aging to examine factors contributing to “price spikes in off-patent drugs,” the Generic Pharmaceutical Association (GPhA) and 10 stakeholder groups representing pharmacists, chain drug stores, pharmacy benefit managers, public and private retirement systems, and others, sent a letter to the Committee calling for consideration of the Fair Access to Safe and Timely (FAST) Generics Act (HR 2841) to improve competition in the pharmaceutical marketplace. 7 January 2016
Pharmaceutical
Australian Health Minister Sussan Ley says she has asked her Department to urgently alert the Australian Competition and Consumer Commission (ACCC) to plans by the maker of Panadol Osteo to increase its price by 50% on January 1, 2016. 31 December 2015
Generics
Skyrocketing generic drug prices in the USA cost taxpayers an additional $1.4 billion over the last decade, according to a new report from the Department of Health and Human Services’ Inspector General, undertaken at the request of Senator Bernie Sanders (Independent, Vermont) and Representative Elijah Cummings (Democrat, Maryland), ranking member of the House Committee on Oversight and Government Reform. 22 December 2015
Pharmaceutical
The US Senate’s special committee on ageing has heard evidence that recent sharp price increases of some medicines could affect patients and lead to supply problems. 11 December 2015
Pharmaceutical
Russia may refuse from further imports of Turkish pharmaceutical products and to complicate doing business in Russia for some leading Turkish drugmakers, operating in Russia, according to some sources in the Russian Ministry of Health, due to current tensions between the two countries. 10 December 2015
Pharmaceutical
The Russian government has restricted purchases of vital foreign drugs for state needs, according to a recent Decree signed this week by Russia’s Prime Minister Dmitry Medvedev, reports The Pharma Letter’s local correspondent. 4 December 2015
Pharmaceutical
At the 26th China-US Joint Commission on Commerce and Trade (JCCT) held in Guangzhou, China, earlier this month, China and the United States agreed to further enhance cooperation in the field of food safety, joint actions against online sales of counterfeit drugs, drug and medical device registration approval and clinical trial, as well as dialogue on cosmetics supervision, in order to protect the health of the public. 30 November 2015
Pharmaceutical
Ukrainian drugmakers may loss their share of the domestic pharmaceutical market over the next several years, due to a recent decision of the national government to sign a contract on public procurement of drugs in Ukraine with UNDP, UNICEF and the British Crown Agents, reports The Pharma Letter’s local correspondent. 30 November 2015
Generics
Cheaper generic drugs may soon be commonplace in India with the government aiming to sell around 400 medications at lower prices by this December, through its Jan Aushadhi stores. 30 November 2015
Pharmaceutical
The Association of the British Pharmaceutical Industry (ABPI) has given a cautionary welcome to the British government’s commitment to protect the science budget. 25 November 2015
Pharmaceutical
British prime minister David Cameron has pledged £150 million ($228 million) to set up the UK’s first Dementia Research Institute. 24 November 2015
Pharmaceutical
The US House of Representatives has approved a public health bill which aims to bring more consistency and transparency to the review process of medicines. 17 November 2015
Biotechnology
AusBiotech, the representative body for the biotech industry in Australia, has said the Patent Box report to the Australian government is too limited to be of use. 17 November 2015
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze